| ID: | 157 | |
|---|---|---|
| Name: | Compound 157 | |
| Description: | Original numeration in publication: 6a | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C29H23N5/c1-3-9-20(10-4-1)26-19-27(32-31-26)21-15-17-23(18-16-21)30-29-25-14-8-7-13-24(25)28(33-34-29)22-11-5-2-6-12-22/h1-18,26,31H,19H2,(H,30,34) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.19 |
Khedr, F.; Ibrahim, M.-K.; Eissa, I. H. a. A., H. S.; El-Adl, K. Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201 |
| 6.45732 |
Eq1: VEGFR-2 inhibition (Data used to train model) |